Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Must-Sit in front of the Programs from Europe and the US - 24 Sound blocking Earphones for Prevalent Sound and Solace
- 3December's overlooked meteor shower peaks next week — will the Ursids surprise us?
- 4'Outrageous and illegal' : UNRWA slams Israel for cutting off its water, comms and electric in Gaza
- 5Selena Quintanilla documentary 'Selena y Los Dinos: A Family's Legacy' is coming to Netflix
- Northern lights chances rise for Christmas as space weather remains unsettled
- As cases of a rare, deadly infection rise, doctors worry fewer teens will get vaccinated
- From Educational Loans to Obligation Free: Independence from the rat race Accomplished
- Vote In favor of Your Number one Kind Of Food Conveyance Administration
- 8 Fundamental Stages: Novice's Manual for Secure Your Android with a VPN
- Second doctor in Matthew Perry overdose case sentenced to home confinement
- The Hybrid Volkswagen ID. ERA 9X Will Become the Brand’s New Flagship in China
- Christopher Nolan's 'The Odyssey' trailer: See Anne Hathaway, Matt Damon and Tom Holland in 1st look at movie
- Pick Your #1 breakfast food
